P. Tønnesen (Glostrup, Denmark), E. Dagli (Istanbul, Turkey)
Use of cytisine for smoking cessation in Italian Centers for Tobacco Treatment R. Principe (ROMA, RM, Italy)
| |
Influence of psychiatric disorders in patients treated with Varenicline. N. Fouz Rosón (Barcelona, Spain)
| |
Characteristics of smokers according to their Nicotine Metabolite Ratio, preliminary results from a real-life experience G. Puppo (Pisa, PI, Italy)
| |
Short-term low-dose vs standard-dose Varenicline therapy for smoking cessation: a randomized controlled trial. N. Fouz Rosón (Barcelona, Spain)
| |
Pharmacological correction of connective tissue dismetabolism in aorta of rats with experimental tobacco smoking V. Nevzorova (Vladivostok, Primorsky Krai, Russian Federation)
| |
Cytisine is an effective smoking cessation medication: more evidence now than ever before D. Vinnikov (Bishkek, Kyrgyzstan)
| |
Medical treatment effectiveness in smoking cessation I. Pešic (Beograd, Republic of Serbia)
| |
A bibliometric overview of e-cigarette publications from 2007 to 2016. F. Filippidis (London, United Kingdom)
| |
Highest prevalence of respiratory symptoms among smokers who also use e-cigarettes L. Hedman (Luleå, Sweden)
| |
Prevalence and knowledge of electronic cigarettes amongst medical students, A cross sectional survey from Karachi, Pakistan N. Iqbal (KARACHI, Pakistan)
| |
Cigarette and e-cigarette smoking among medical and non-medical students in Poland G. Brozek (Katowice, Poland)
| |
Symptoms reported by electronic-cigarettes users in social media E. Dagli (Istanbul, Turkey)
| |
Analysis of an electronic cigarette social media forum E. Dagli (Istanbul, Turkey)
| |
The impact of cigarette and e-cigarette smoking on human health. M. Jankowski (Katowice, Poland)
| |